Mutual Of America Capital Management LLC Beam Therapeutics Inc. Transaction History

Mutual Of America Capital Management LLC

  • $9.32 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023
SELL
$30.15 - $48.79 $36,843 - $59,621
-1,222 Reduced 4.4%
26,531 $812,000
Q4 2022

Feb 10, 2023
BUY
$36.73 - $51.6 $229,489 - $322,396
6,248 Added 29.05%
27,753 $1.09 Million
Q3 2022

Nov 08, 2022
BUY
$39.79 - $70.31 $855,683 - $1.51 Million
21,505 New
21,505 $1.02 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email